Skip to search formSkip to main contentSkip to account menu

Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20

Known as: CIPN20 Questionnaire, EORTC QLQ-CIPN20 
A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 20 questions designed to assess… 
National Institutes of Health

Related topics

Related topics

5 relations
Have Blurry EyesightHave Difficulty Distinguishing Between Hot and Cold WaterHave Difficulty HearingHave Difficulty Manipulating Small Objects with Fingers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy
Oxaliplatin is widely used in the treatment of gastrointestinal malignancies. One of the most common and dose-limiting side… 
2019
2019
Quality of life is maintained with ixazomib maintenance in post‐transplant newly diagnosed multiple myeloma: The TOURMALINE‐MM3 trial
Health‐related quality of life (HRQoL) is particularly important during maintenance therapy (MT) in newly diagnosed multiple… 
2018
2018
Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using…
PurposeTo test the psychometric properties of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of… 
2016
2016
Health Related Quality of Life in Patients with Lung Cancer in Morocco
Background: The Moroccan perspective on quality of life (QOL) in lung cancer has not been studied adequately in a country where… 
2016
2016
Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients.
10098Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity of several commonly used… 
2016
2016
Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.
4543Background: CIPN is a potentially permanent side effect of cisplatin chemotherapy. CIPN remains a major clinical challenge… 
Review
2015
Review
2015
The prevalence and pattern of chemotherapy-induced peripheral neuropathy (CIPN) among women with breast cancer receiving care in a large community oncology practice.
80 Background: CIPN is a common side effect of taxane-based chemotherapy agents. This study examined the prevalence, severity… 
2014
2014
578PADJUVANT OXALIPLATIN DOSE AND DOSE REDUCTIONS ARE ASSOCIATED WITH SEVERITY OF PERIPHERAL NEUROPATHY AMONG COLORECTAL CANCER SURVIVORS: RESULTS FROM THE POPULATION-BASED PROFILES REGISTRY.
ABSTRACT Aim: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of oxaliplatin which can… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)